The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Behbahani Ali since year 2005.
The trader's CIK number is 1613867.
At the time of the last reporting, Behbahani Ali was the Director of Black Diamond Therapeutics, Inc. .
(stock ticker symbol BDTX).
See this page for all insider trading activities at Black Diamond Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2020-02-03||BDTX||Black Diamond Therapeutics, Inc.||Buy||800,000||19.00||15,200,000|
|2020-01-24||ADAP||Adaptimmune Therapeutics Plc||Buy||7,500,000||.67||5,002,500|
|2019-07-22||MIRM||Mirum Pharmaceuticals, Inc.||Buy||450,000||15.00||6,750,000|
|2019-06-24||GNCA||Genocea Biosciences, Inc.||Buy||2,857,142||3.50||9,999,997|
|2019-05-09||TRVI||Trevi Therapeutics, Inc.||Buy||2,500,000||10.00||25,000,000|
|2019-05-07||RGLS||Regulus Therapeutics Inc.||Buy||1,136,704||1.08||1,227,640|
|2019-02-14||GNCA||Genocea Biosciences, Inc.||Buy||9,948,269||.47||4,685,634|
|2018-09-07||ADAP||Adaptimmune Therapeutics Plc||Buy||12,000,000||1.67||20,004,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Behbahani Ali (Director of Black Diamond Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.